Novartis Institutes for Biomedical Research (NIBR) is the global pharmaceutical research organization of Novartis. It focuses on discovering and developing innovative medicines to address unmet medical needs and improve patient outcomes. NIBR is a key component of Novartis' research and development efforts, driving an industry-leading pipeline of new therapies.
Focus Areas
Notable Investments
